Clinical Trials Logo
  1. Home
  2. Coronary Restenosis
  3. NCT02300454

Effect of Combination of Non-sLip Element Balloon (NSE) and druG-coated bAlloon (DCB) for In-steNT Restenosis Lesions — ELEGANT  

Coronary Restenosis Clinical Trial

Clinical Trial Summary

Use of SeQuent® Please drug coated balloon (DCB) is effective to treat patients with in-stent restenosis (ISR). However, whether the type of pre-dilatation balloon prior to DCB dilatation impacts on clinical and angiographic outcomes or not is unknown. Lacrosse® Non-slip element balloon (NSE) is a balloon catheter with 3 longitudinal plastic elements which are attached to proximal and distal balloon edges. NSE is developed to incise neointimal tissue and avoid balloon slippage without vitiating balloon derivability and crossability. We investigated angiographic and clinical outcomes following normal non-compliant balloon or NSE dilatation prior to DCB dilatation in ISR lesions.This study is a single blinded, multicenter, randomized trial. Total 200 patients with ISR are randomly assigned to treat with non-compliant balloon or NSE before DCB dilatation. Optical coherence tomographic (OCT) analysis are performed before pre-dilatation and after DCB dilatation Follow-up angiography analysis are planned at 8 months in all patients. Clinical follow-up is planned at 8 and 24 months.Primary endpoint is angiographic in-segment late loss at 8 months.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02300454
Study type Interventional
Source Mitsui Memorial Hospital
Contact
Status Active, not recruiting
Phase Phase 4
Start date June 2015
Completion date April 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT01205776 - EXCEL Clinical Trial N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Completed NCT02263313 - EGO-COMBO Clinical End-point Extension Study Beyond 36 Months N/A
Completed NCT00248066 - Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries Phase 2
Completed NCT00148356 - Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries Phase 2/Phase 3
Active, not recruiting NCT02508714 - Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents N/A
Completed NCT01274234 - OCT Evaluation of Healing of COMBO Stent Phase 1/Phase 2
Completed NCT01205789 - EXCEL Clinical Trial (Universal Registry) N/A
Recruiting NCT00426049 - Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation Phase 3
Terminated NCT00243308 - Serp-1 for the Treatment of Acute Coronary Syndrome Phase 2
Completed NCT00180466 - PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions N/A
Completed NCT00859183 - Oral Sirolimus for In-Stent Restenosis Phase 4
Completed NCT03667313 - Treatment of In-Stent Restenosis 2 Study Phase 3
Recruiting NCT05089864 - STAR and Deferred Stenting Study N/A
Active, not recruiting NCT02175706 - DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity N/A
Completed NCT01331707 - DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population Phase 4
Completed NCT01249027 - XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study
Recruiting NCT00500279 - Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial Phase 4
Completed NCT01171820 - SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study) Phase 4
Completed NCT00402272 - SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe Phase 4